Non-small cell lung cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Histologically or cytologically confirmed NSCLC; 2. Normal physiological functions of the viscera as heart, liver, kidney and bone marrow; 3. ECOG performance status 0-1; 4. Life expectancy of at least 3 months; 5. At least one measurable lesion; 6. Aged 18-80 years; 7. Patients prepared for platinum-based chemotherapy with signed informed consent; 8. CTC counts of more than 8.5 CU in 3mL blood before therapy.
Exclusion criteria
Exclusion criteria: 1. Concurrent other cancers or other serious diseases (except for non-melanoma skin cancer and in situ cervical cancers) within 5 years prior to study enrollment; 2. Previous anti-cancer therapy within 6 months prior to study enrollment; 3. Symptomatic brain metastases, uncontrolled serious effusions; 4. Inability to comply with study and/or follow-up procedures; Inability to obtain informed consent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| CTC; | — |
Countries
China